Biggest News Aggregation in the World
📰 Arnaud Delepine News

Page 4 - Arnaud Delepine News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Arnaud Delepine. Real-time updates on events, politics, business and more.

Sanofi - Aventis Groupe: Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline of innovative vaccine candidates

Vaccines Investor Event: Sanofi reiterates confidence in strong growth outlook and showcases pipeline of innovative vaccine candidates Sanofi confirms Vaccines mid-term guidance
United States France General Eva Schaefer Jansen Ccorentine Driancourt Nicolas Obrist Arnaud Delepine

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sanofi: Dupixent (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease

Dupixent (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease Pivotal
France General United States Eva Schaefer Jansen Arnaud Delepine Felix Lauscher John Reed

Sanofi: New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021

New long-term data reinforcing promising safety and efficacy profile of brain-penetrant tolebrutinib presented at ECTRIMS 2021 One-year results from Phase 2b extension study of brain-penetrant tolebrutinib
United States France General United Kingdom Eva Schaefer Jansen Erik Wallstr Arnaud Delepine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science